DXCM
NASDAQ · Health Care
Dexcom Inc
$84.75
+1.73 (+2.08%)
Financial Highlights (FY 2026)
Revenue
4.22B
Net Income
757.33M
Gross Margin
62.1%
Profit Margin
17.9%
Rev Growth
+17.0%
D/E Ratio
0.47
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 62.1% | 62.1% | 53.6% | 53.6% |
| Operating Margin | 19.6% | 17.6% | 10.9% | 10.3% |
| Profit Margin | 17.9% | 17.0% | 6.6% | 7.6% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 4.22B | 3.61B | 12.36B | 9.93B |
| Gross Profit | 2.62B | 2.24B | 6.63B | 5.32B |
| Operating Income | 825.78M | 635.16M | 1.35B | 1.02B |
| Net Income | 757.33M | 582.51M | 814.68M | 758.06M |
| Gross Margin | 62.1% | 62.1% | 53.6% | 53.6% |
| Operating Margin | 19.6% | 17.6% | 10.9% | 10.3% |
| Profit Margin | 17.9% | 17.0% | 6.6% | 7.6% |
| Rev Growth | +17.0% | +17.0% | +22.1% | +18.1% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 4.99B | 4.99B | 4.52B | 3.50B |
| Total Equity | 10.57B | 10.57B | 20.60B | 23.78B |
| D/E Ratio | 0.47 | 0.47 | 0.22 | 0.15 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 1.05B | 855.50M | 1.58B | 1.10B |
| Free Cash Flow | — | — | 995.22M | 889.53M |